We're launching a study that aims to reduce the risk of #COVID19 for #immunocompromised individuals.
We hypothesize that detecting and treating COVID quickly can improve outcomes.
The study is completely remote and available across the US at: immunocare.scripps.edu
1/3
We hypothesize that detecting and treating COVID quickly can improve outcomes.
The study is completely remote and available across the US at: immunocare.scripps.edu
1/3
Eligible participants will receive 10 @CueHealth tests per month as well as access to Cue's on-demand telehealth and prescription delivery services at no cost.
These tests are much more sensitive than antigen tests.
immunocare.scripps.edu
2/3
These tests are much more sensitive than antigen tests.
immunocare.scripps.edu
2/3
I hope this helps the immunocompromised community. I know what a challenge it can be to have such different risk/benefit calculations from those around you.
Feel free to share with the immunocompromised people in your life.
immunocare.scripps.edu
3/3
Feel free to share with the immunocompromised people in your life.
immunocare.scripps.edu
3/3
• • •
Missing some Tweet in this thread? You can try to
force a refresh
